Defective structural RNA processing in relapsing-remitting multiple sclerosis.

Charles F Spurlock, John T Tossberg, Yan Guo, Subramaniam Sriram, Philip S Crooke, Thomas M Aune
Author Information
  1. Charles F Spurlock: Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. chase.spurlock@vanderbilt.edu.
  2. John T Tossberg: Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. john.t.tossberg@vanderbilt.edu.
  3. Yan Guo: Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. yan.guo@vanderbilt.edu.
  4. Subramaniam Sriram: Department of Neurology, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. subramaniam.sriram@vanderbilt.edu.
  5. Philip S Crooke: Department of Mathematics, Vanderbilt University, Nashville, TN, 37232, USA. phil.crooke@vanderbilt.edu.
  6. Thomas M Aune: Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA. tom.aune@vanderbilt.edu.

Abstract

BACKGROUND: Surveillance of integrity of the basic elements of the cell including DNA, RNA, and proteins is a critical element of cellular physiology. Mechanisms of surveillance of DNA and protein integrity are well understood. Surveillance of structural RNAs making up the vast majority of RNA in a cell is less well understood. Here, we sought to explore integrity of processing of structural RNAs in relapsing remitting multiple sclerosis (RRMS) and other inflammatory diseases.
RESULTS: We employed mononuclear cells obtained from subjects with RRMS and cell lines. We used quantitative-PCR and whole genome RNA sequencing to define defects in structural RNA surveillance and siRNAs to deplete target proteins. We report profound defects in surveillance of structural RNAs in RRMS exemplified by elevated levels of poly(A) + Y1-RNA, poly(A) + 18S rRNA and 28S rRNAs, elevated levels of misprocessed 18S and 28S rRNAs and levels of the U-class of small nuclear RNAs. Multiple sclerosis is also associated with genome-wide defects in mRNA splicing. Ro60 and La proteins, which exist in ribonucleoprotein particles and play different roles in quality control of structural RNAs, are also deficient in RRMS. In cell lines, silencing of the genes encoding Ro60 and La proteins gives rise to these same defects in surveillance of structural RNAs.
CONCLUSIONS: Our results establish that profound defects in structural RNA surveillance exist in RRMS and establish a causal link between Ro60 and La proteins and integrity of structural RNAs.

References

  1. Cell. 2012 Jul 6;150(1):53-64 [PMID: 22770214]
  2. Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7407-12 [PMID: 20368444]
  3. Genome Res. 2013 Feb;23(2):281-91 [PMID: 23070852]
  4. EMBO Mol Med. 2013 Feb;5(2):221-34 [PMID: 23255347]
  5. J Cell Biol. 2013 Mar 4;200(5):577-88 [PMID: 23439679]
  6. Cell. 2013 Mar 28;153(1):166-77 [PMID: 23540697]
  7. Nucleic Acids Res. 2013 Apr;41(8):4709-23 [PMID: 23482395]
  8. Arthritis Rheumatol. 2014 Nov;66(11):2947-57 [PMID: 25077978]
  9. Nat Biotechnol. 2010 May;28(5):511-5 [PMID: 20436464]
  10. PLoS One. 2010;5(10):e13673 [PMID: 21060685]
  11. Nature. 2010 Dec 2;468(7324):664-8 [PMID: 20881964]
  12. Ann Neurol. 2011 Jan;69(1):65-74 [PMID: 21280076]
  13. Wiley Interdiscip Rev RNA. 2011 Sep-Oct;2(5):686-99 [PMID: 21823229]
  14. Nature. 2011 Aug 11;476(7359):214-9 [PMID: 21833088]
  15. Arthritis Rheum. 2011 Sep;63(9):2606-16 [PMID: 21618198]
  16. J Biol Chem. 2011 Oct 28;286(43):37429-45 [PMID: 21878619]
  17. Cell. 2012 Jan 20;148(1-2):296-308 [PMID: 22265417]
  18. PLoS One. 2012;7(2):e30619 [PMID: 22312429]
  19. Arthritis Rheum. 2012 Jun;64(6):1780-9 [PMID: 22183962]
  20. Trends Genet. 2012 Jul;28(7):306-13 [PMID: 22475369]
  21. Rheumatology (Oxford). 2015 Jan;54(1):178-87 [PMID: 25118313]
  22. N Engl J Med. 2000 Sep 28;343(13):938-52 [PMID: 11006371]
  23. Glia. 2002 Mar 1;37(3):219-28 [PMID: 11857680]
  24. Lancet. 2002 Apr 6;359(9313):1221-31 [PMID: 11955556]
  25. J Neuroimmunol. 2002 Jun;127(1-2):1-12 [PMID: 12044969]
  26. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7503-8 [PMID: 12788971]
  27. Bioessays. 2003 Dec;25(12):1147-9 [PMID: 14635248]
  28. Curr Biol. 2003 Dec 16;13(24):2206-11 [PMID: 14680639]
  29. J Neuroimmunol. 2004 Jul;152(1-2):57-66 [PMID: 15223237]
  30. Neurology. 1993 Apr;43(4):662-7 [PMID: 8469319]
  31. Cell. 1995 Jan 13;80(1):155-65 [PMID: 7813012]
  32. Prog Nucleic Acid Res Mol Biol. 1994;49:197-239 [PMID: 7863007]
  33. Lancet. 1995 Dec 23-30;346(8991-8992):1712-3 [PMID: 8551862]
  34. Hum Mol Genet. 1997 Aug;6(8):1205-14 [PMID: 9259265]
  35. RNA. 1998 Jul;4(7):750-65 [PMID: 9671049]
  36. Cell. 2005 Jun 3;121(5):713-24 [PMID: 15935758]
  37. Ann Neurol. 2005 Dec;58(6):939-45 [PMID: 16315280]
  38. Mol Vis. 2006;12:1259-71 [PMID: 17110909]
  39. Bioessays. 2007 Mar;29(3):288-99 [PMID: 17295292]
  40. Ann Neurol. 2007 Apr;61(4):288-99 [PMID: 17444504]
  41. Cell. 2007 Jun 29;129(7):1311-23 [PMID: 17604720]
  42. Ann Neurol. 2007 Jun;61(6):504-13 [PMID: 17492755]
  43. Mol Biol Evol. 2007 Aug;24(8):1678-89 [PMID: 17470436]
  44. Cell. 2008 May 16;133(4):585-600 [PMID: 18485868]
  45. Mol Cell Biol. 2008 Nov;28(21):6620-31 [PMID: 18765642]
  46. Lancet. 2008 Oct 25;372(9648):1502-17 [PMID: 18970977]
  47. Cell. 2009 Feb 20;136(4):701-18 [PMID: 19239890]
  48. Cell. 2009 Feb 20;136(4):763-76 [PMID: 19239894]
  49. Cell. 2009 Feb 20;136(4):777-93 [PMID: 19239895]
  50. Bioinformatics. 2009 May 1;25(9):1105-11 [PMID: 19289445]
  51. Neurology. 2009 Jun 2;72(22):1922-30 [PMID: 19487650]
  52. Proc Natl Acad Sci U S A. 2009 Jul 14;106(28):11667-72 [PMID: 19571010]
  53. Nat Rev Neurol. 2009 Dec;5(12):672-82 [PMID: 19953117]
  54. EMBO Rep. 2010 Feb;11(2):106-11 [PMID: 20062005]
  55. Nature. 2012 Sep 6;489(7414):57-74 [PMID: 22955616]

Grants

  1. R41 AI053984/NIAID NIH HHS
  2. R56 AI044924/NIAID NIH HHS
  3. AI053984/NIAID NIH HHS
  4. R42 AI053984/NIAID NIH HHS
  5. AI044924/NIAID NIH HHS
  6. ULITR000445/PHS HHS
  7. /Canadian Institutes of Health Research
  8. R01 AI044924/NIAID NIH HHS

MeSH Term

Autoantigens
Gene Expression
Genomic Structural Variation
High-Throughput Nucleotide Sequencing
Humans
Leukocytes, Mononuclear
Multiple Sclerosis, Relapsing-Remitting
Phosphoproteins
Poly A
RNA Splicing
RNA Stability
RNA, Ribosomal, 18S
RNA, Ribosomal, 28S
RNA, Small Cytoplasmic
RNA, Small Interfering
Ribonucleoproteins

Chemicals

Autoantigens
La protein, human
Phosphoproteins
RNA, Ribosomal, 18S
RNA, Ribosomal, 28S
RNA, Small Cytoplasmic
RNA, Small Interfering
RO60 protein, human
Ribonucleoproteins
Poly A